Paroxetine/Prednisolone

帕罗西汀/泼尼松龙

Report date: 2022/01/14 13:23:58

Base Information

Drug NameParoxetine/Prednisolone
Drug Alias Name帕罗西汀+泼尼松龙Paroxetine+PrednisolonePrednisolone/Paroxetine泼尼松龙+帕罗西汀Prednisolone+Paroxetine +[7] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionSerotonin transporter inhibitorsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptorSerotonin transporter
Therapy Area/IndicationsInflammationArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes PrednisoloneParoxetine hydrochloride
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCombinatorx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCombinatorx
Active IndicationsN/A
Inactive IndicationsInflammationArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A